Sayana Press UK Self-Injection Study
PHASE IV OPEN LABEL SINGLE GROUP ONE YEAR STUDY OF HOME SELF-INJECTION WITH SAYANA (REGISTERED) PRESS IN ADULT WOMEN OF REPRODUCTIVE AGE - A PRAGMATIC CLINICAL TRIAL
Sponsor: Pfizer
A PHASE4 clinical study on Contraception, this trial is completed. The trial is conducted by Pfizer and has accumulated 17 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 12 earlier versions
-
Mar 2019 — Nov 2019 [monthly]
Completed PHASE4
-
Jan 2019 — Mar 2019 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE4
-
Sep 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE4
-
Jul 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Oct 2017 — Dec 2017 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2017 — Aug 2017 [monthly]
Not Yet Recruiting PHASE4
-
Apr 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE4
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .